These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23919478)

  • 21. Dry powder inhalers: an overview.
    Atkins PJ
    Respir Care; 2005 Oct; 50(10):1304-12; discussion 1312. PubMed ID: 16185366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures.
    Elhissi AM; Faizi M; Naji WF; Gill HS; Taylor KM
    Int J Pharm; 2007 Apr; 334(1-2):62-70. PubMed ID: 17123757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Basic techniques for aerosol delivery during mechanical ventilation.
    Dhand R
    Respir Care; 2004 Jun; 49(6):611-22. PubMed ID: 15165296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler.
    Geller DE
    Respir Care; 2005 Oct; 50(10):1313-21; discussion 1321-2. PubMed ID: 16185367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of systemic diseases by inhalation of biomolecule aerosols.
    Siekmeier R; Scheuch G
    J Physiol Pharmacol; 2009 Nov; 60 Suppl 5():15-26. PubMed ID: 20134033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vibrating-mesh nebulization of liposomes generated using an ethanol-based proliposome technology.
    Elhissi A; Gill H; Ahmed W; Taylor K
    J Liposome Res; 2011 Jun; 21(2):173-80. PubMed ID: 20684671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stabilization of liposomes during drying.
    Ingvarsson PT; Yang M; Nielsen HM; Rantanen J; Foged C
    Expert Opin Drug Deliv; 2011 Mar; 8(3):375-88. PubMed ID: 21294603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary formulations: what remains to be done?
    Weers JG; Bell J; Chan HK; Cipolla D; Dunbar C; Hickey AJ; Smith IJ
    J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23 Suppl 2():S5-23. PubMed ID: 21133800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors influencing polycation/siRNA colloidal stability toward aerosol lung delivery.
    Steele TW; Zhao X; Tarcha P; Kissel T
    Eur J Pharm Biopharm; 2012 Jan; 80(1):14-24. PubMed ID: 21924355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aerosol performance and long-term stability of surfactant-associated liposomal ciprofloxacin formulations with modified encapsulation and release properties.
    Cipolla D; Wu H; Gonda I; Chan HK
    AAPS PharmSciTech; 2014 Oct; 15(5):1218-27. PubMed ID: 24889736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of nebulizer type with different pediatric aerosol masks on drug deposition in a model of a spontaneously breathing small child.
    Lin HL; Wan GH; Chen YH; Fink JB; Liu WQ; Liu KY
    Respir Care; 2012 Nov; 57(11):1894-900. PubMed ID: 22418694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Smart nebulizers.
    Smaldone GC
    Respir Care; 2002 Dec; 47(12):1434-41; discussion 1441-4. PubMed ID: 12467501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhalation aspects of therapeutic aerosols.
    Leach CL
    Toxicol Pathol; 2007 Jan; 35(1):23-6. PubMed ID: 17325969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Future directions in aerosol therapy.
    Dhand R
    Respir Care Clin N Am; 2001 Jun; 7(2):319-35, vii. PubMed ID: 11517026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic liposomal dry powder inhalation aerosols for targeted lung delivery.
    Willis L; Hayes D; Mansour HM
    Lung; 2012 Jun; 190(3):251-62. PubMed ID: 22274758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro characterization of nebulizer delivery of liposomal amphotericin B aerosols.
    Alexander BD; Winkler TP; Shi S; Dodds Ashley ES; Hickey AJ
    Pharm Dev Technol; 2011; 16(6):577-82. PubMed ID: 21699390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adaptive Aerosol Delivery (AAD) technology.
    Denyer J; Nikander K; Smith NJ
    Expert Opin Drug Deliv; 2004 Nov; 1(1):165-76. PubMed ID: 16296727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disposition kinetics of ketotifen from liposomal dry powder for inhalation in rat lung.
    Joshi M; Misra A
    Clin Exp Pharmacol Physiol; 2003 Mar; 30(3):153-6. PubMed ID: 12603343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aerosolized liposome-based delivery of amphotericin B to alveolar macrophages.
    Vyas SP; Quraishi S; Gupta S; Jaganathan KS
    Int J Pharm; 2005 May; 296(1-2):12-25. PubMed ID: 15885451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
    de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):81-9. PubMed ID: 16442246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.